Engineered cellular IL-1B is rapidly becoming a critical resource for scientists across several fields. Such thoroughly produced Recombinant Human IL-1B version of interleukin-1 beta provides advantages over endogenously present IL-1B, including enhanced cleanliness and predictable activity. Scientists are employing it to better explore the role of